436 related articles for article (PubMed ID: 23247231)
1. The impact of comorbidity on treatment (chemoradiation and laryngectomy) of advanced, nondistant metastatic laryngeal cancer: a review of 16 849 cases from the national cancer database (2003-2008).
Zhu J; Fedewa S; Chen AY
Arch Otolaryngol Head Neck Surg; 2012 Dec; 138(12):1120-8. PubMed ID: 23247231
[TBL] [Abstract][Full Text] [Related]
2. Temporal trends in the treatment of early- and advanced-stage laryngeal cancer in the United States, 1985-2007.
Chen AY; Fedewa S; Zhu J
Arch Otolaryngol Head Neck Surg; 2011 Oct; 137(10):1017-24. PubMed ID: 22006780
[TBL] [Abstract][Full Text] [Related]
3. Survival outcomes in advanced laryngeal cancer.
Megwalu UC; Sikora AG
JAMA Otolaryngol Head Neck Surg; 2014 Sep; 140(9):855-60. PubMed ID: 25144163
[TBL] [Abstract][Full Text] [Related]
4. Improvements in survival and disparities for advanced-stage laryngeal cancer.
LeBlanc BJ; Shi R; Mehta V; Mills G; Ampil F; Nathan CA
JAMA Otolaryngol Head Neck Surg; 2015 Feb; 141(2):169-73. PubMed ID: 25429594
[TBL] [Abstract][Full Text] [Related]
5. Health insurance and stage at diagnosis of laryngeal cancer: does insurance type predict stage at diagnosis?
Chen AY; Schrag NM; Halpern M; Stewart A; Ward EM
Arch Otolaryngol Head Neck Surg; 2007 Aug; 133(8):784-90. PubMed ID: 17709617
[TBL] [Abstract][Full Text] [Related]
6. Improved survival is associated with treatment at high-volume teaching facilities for patients with advanced stage laryngeal cancer.
Chen AY; Fedewa S; Pavluck A; Ward EM
Cancer; 2010 Oct; 116(20):4744-52. PubMed ID: 20589761
[TBL] [Abstract][Full Text] [Related]
7. Total Laryngectomy Versus Larynx Preservation for T4a Larynx Cancer: Patterns of Care and Survival Outcomes.
Grover S; Swisher-McClure S; Mitra N; Li J; Cohen RB; Ahn PH; Lukens JN; Chalian AA; Weinstein GS; O'Malley BW; Lin A
Int J Radiat Oncol Biol Phys; 2015 Jul; 92(3):594-601. PubMed ID: 26068492
[TBL] [Abstract][Full Text] [Related]
8. Significance of laryngeal edema after partial laryngectomy and radiotherapy in supraglottic cancer.
Oksüz DC; Uzel O; Yildirim A; Yetmen O; Sahinler I; Turkan S
J Otolaryngol Head Neck Surg; 2008 Oct; 37(5):681-8. PubMed ID: 19128676
[TBL] [Abstract][Full Text] [Related]
9. Management of stage IV glottic carcinoma: therapeutic outcomes.
Spector GJ; Sessions DG; Lenox J; Newland D; Simpson J; Haughey BH
Laryngoscope; 2004 Aug; 114(8):1438-46. PubMed ID: 15280724
[TBL] [Abstract][Full Text] [Related]
10. Voice and swallowing outcomes of an organ-preservation trial for advanced laryngeal cancer.
Fung K; Lyden TH; Lee J; Urba SG; Worden F; Eisbruch A; Tsien C; Bradford CR; Chepeha DB; Hogikyan ND; Prince ME; Teknos TN; Wolf GT
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1395-9. PubMed ID: 16087298
[TBL] [Abstract][Full Text] [Related]
11. Comparison of quality of life outcomes in laryngeal cancer patients following chemoradiation vs. total laryngectomy.
LoTempio MM; Wang KH; Sadeghi A; Delacure MD; Juillard GF; Wang MB
Otolaryngol Head Neck Surg; 2005 Jun; 132(6):948-53. PubMed ID: 15944570
[TBL] [Abstract][Full Text] [Related]
12. Comparison of quality of life in advanced laryngeal cancer patients after concurrent chemoradiotherapy vs total laryngectomy.
Trivedi NP; Swaminathan DK; Thankappan K; Chatni S; Kuriakose MA; Iyer S
Otolaryngol Head Neck Surg; 2008 Nov; 139(5):702-7. PubMed ID: 18984267
[TBL] [Abstract][Full Text] [Related]
13. Use of concurrent chemoradiation in advanced staged (T4) laryngeal cancer.
Wick CC; Rezaee RP; Wang T; Garcia-Jarchow AM; Zender CA; Gibson M; Yao M; Lavertu P
Am J Otolaryngol; 2017; 38(1):72-76. PubMed ID: 27838151
[TBL] [Abstract][Full Text] [Related]
14. Salvage laryngectomy in patients with recurrent laryngeal cancer in the setting of nonoperative treatment failure.
Li M; Lorenz RR; Khan MJ; Burkey BB; Adelstein DJ; Greskovich JF; Koyfman SA; Scharpf J
Otolaryngol Head Neck Surg; 2013 Aug; 149(2):245-51. PubMed ID: 23585149
[TBL] [Abstract][Full Text] [Related]
15. Long-term follow-up and salvage surgery in patients with T2N0M0 squamous cell carcinoma of the glottic larynx following concurrent chemoradiation therapy with cisplatin and 5-fluorouracil for laryngeal preservation.
Furusaka T; Susaki Y; Saito T; Katsura Y; Ikeda M
Acta Otolaryngol; 2013 Jan; 133(1):91-8. PubMed ID: 23106387
[TBL] [Abstract][Full Text] [Related]
16. Tumor volumetry as a prognostic factor in the management of T4a laryngeal cancer.
Hsin LJ; Fang TJ; Tsang NM; Chin SC; Yen TC; Li HY; Liao CT; Chen IH
Laryngoscope; 2014 May; 124(5):1134-40. PubMed ID: 24127228
[TBL] [Abstract][Full Text] [Related]
17. Quality of life for patients following total laryngectomy vs chemoradiation for laryngeal preservation.
Hanna E; Sherman A; Cash D; Adams D; Vural E; Fan CY; Suen JY
Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):875-9. PubMed ID: 15262766
[TBL] [Abstract][Full Text] [Related]
18. Effect of comorbidity on quality of life and treatment selection in patients with squamous cell carcinoma of the head and neck.
Gourin CG; McAfee WJ; Neyman KM; Howington JW; Podolsky RH; Terris DJ
Laryngoscope; 2005 Aug; 115(8):1371-5. PubMed ID: 16094107
[TBL] [Abstract][Full Text] [Related]
19. [Results of definitive radiotherapy for squamous cell carcinomas of the larynx patients with subglottic extension].
Lévy A; Blanchard P; Janot F; Temam S; Bourhis J; Daly-Schveitzer N; Tao Y
Cancer Radiother; 2014 Jan; 18(1):1-6. PubMed ID: 24309002
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of basaloid squamous cell carcinoma in head and neck cancer.
Linton OR; Moore MG; Brigance JS; Gordon CA; Summerlin DJ; McDonald MW
JAMA Otolaryngol Head Neck Surg; 2013 Dec; 139(12):1306-11. PubMed ID: 24158536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
